The insider sales are routine liquidity events tied to option exercises and do not signal a bearish view given the trivial proportion of market cap. Monitor for any material news (pipeline data, regulatory updates) that could explain the timing, but the cluster itself is not actionable. The strong historical win rate on RVMD reports (90%) suggests the stock has been trending positively, but this cluster does not change the narrative.
Price Chart
Executive Summary
Two insiders at Revolution Medicines — General Counsel Jeff Cislini and Director Mark Goldsmith — sold a combined ~$22.5M in open-market sales on August 21, 2026, following option exercises. The total open-market sales of ~$22.5M represent approximately 0.05% of RVMD's $45.3B market cap, which is below the 0.1% threshold for materiality. While the cluster timing is notable (same-day sales by both insiders), the dollar amount relative to market cap is trivial, and the sales are clearly tied to option exercises (liquidity-driven, not informational). The historical calibration shows strong past performance on RVMD reports (90% win rate, +12.82% avg T+20), but this cluster does not warrant a directional call given the proportionality check.
Key Financial Metrics
Key Facts
- Two insiders sold shares on August 21, 2026: General Counsel Jeff Cislini and Director Mark Goldsmith
- Total open-market sales: ~$22.5M (Cislini: ~$11.9M, Goldsmith: ~$10.5M)
- All sales followed option exercises — Cislini exercised options at $0 and $18.56-$21.61 strike, Goldsmith exercised options at $0 strike
- Total sales represent ~0.05% of RVMD's $45.3B market cap — below the 0.1% materiality threshold
- No insider buying in the cluster — net direction is selling
- RVMD has 93% analyst bullish consensus (26 Buy/10 Strong Buy out of 28 analysts)
Financial Impact
Total open-market sales of ~$22.5M represent ~0.05% of market cap — trivial relative to company size
Risk Factors
- Insider sales could accelerate if the stock continues its strong run (up ~12%+ on average per prior reports)
- Option exercises increase share count modestly, though the dilution is immaterial at this scale
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RVMD-1787728254135 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | 144 | $195.92 $190.74 | ▼ −2.64% | ▼ −5.21% | $206.29 (+5.29%) |
Sep 15, 2026 16d ago | 144 | $195.92 $190.74 | ▼ −2.64% | ▼ −5.21% | $206.29 (+5.29%) |
Sep 15, 2026 17d ago | Insider Cluster | $204.86 $190.95 | ▼ −6.79% | ▼ −7.61% | $206.29 (+0.70%) |
Sep 14, 2026 17d ago | Insider Cluster | $204.86 $192.86 | ▼ −5.86% | ▼ −7.98% | $206.29 (+0.70%) |
Aug 26, 2026 5w ago | 8-K | $215.44 $209.23 | ▼ −2.88% | ▼ −2.76% | $206.29 (−4.25%) |
Aug 26, 2026 5w ago | Press Release | $215.44 $209.23 | ▼ −2.88% | ▼ −2.76% | $206.29 (−4.25%) |
Aug 25, 2026 5w ago | Insider Cluster | $211.38 $209.87 | ▼ −0.71% | ▼ −0.18% | $206.29 (−2.41%) |
Jul 2, 2026 13w ago | Press Release | $189.24 $191.13 | ▲ +1.00% | ▲ +0.07% | $206.29 (+9.01%) |
Jul 1, 2026 13w ago | Insider Cluster | $187.51 $190.46 | ▲ +1.57% | ▲ +1.31% | $206.29 (+10.02%) |
Jun 22, 2026 14w ago | 8-K | $165.81 $192.62 | ▲ +16.17% | ▲ +16.62% | $206.29 (+24.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access